Intercept Pharmaceuticals Investor Relations Material
Latest events
Q2 2023
Intercept Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Intercept Pharmaceuticals Inc
Access all reports
Intercept Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for chronic liver diseases. The company’s research includes treatments for conditions such as primary biliary cholangitis and nonalcoholic steatohepatitis. Intercept Pharmaceuticals Inc is headquartered in Morristown, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
ICPT
Country
🇺🇸 United States